EUVIMEDEUVIMED entdecken
Open Access

A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response

Animesh Kar iD, Dolly Jain iD, Sandeep Kumar iD, Kajal Rajput iD, Sanjay Pal iD, Kajal Rana iD, Raunak Kar iD, Somesh K Jha iD, Nihal Medatwal iD, Prabhu Srinivas Yavvari iD, Nishant Pandey iD, Devashish Mehta iD und 11 weitere

Science Advances · 2023

DOI: 10.1126/sciadv.adf2746 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Animesh Kar und 22 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon E…. Hauptthemen laut MEDLINE: Hydrogels, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment of triple-negative breast cancer (TNBC) is challenging because of its “COLD” tumor immunosuppressive microenvironment (TIME). Here, we present a hydrogel-mediated localized delivery of a combination of docetaxel (DTX) and carboplatin (CPT) (called DTX-CPT-Gel therapy) that ensured enhanced anticancer effect and tumor regression on multiple murine syngeneic and xenograft tumor models. DTX-CPT-Gel therapy modulated the TIME by an increase of antitumorigenic M1 macrophages, attenuation of myeloid-derived suppressor cells, and increase of granzyme B + CD8 + T cells. DTX-CPT-Gel therapy elevated ceramide levels in tumor tissues that activated the protein kinase R (PKR)–like endoplasmic reticulum kinase (PERK)–mediated unfolded protein response (UPR). This UPR-mediated activation of apoptotic cell death led to release of damage-associated molecular patterns, thereby activating the immunogenic cell death that could even clear the metastatic tumors. This study provides a promising hydrogel-mediated platform for DTX-CPT therapy that induces tumor regression and effective immune modulation and, therefore, can be explored further for treatment of TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsTriple Negative Breast NeoplasmsHumansAnimalsMiceImmunogenic Cell DeathCD8-Positive T-LymphocytesCeramidesDisease Models, AnimalImmunosuppressive AgentsUnfolded Protein ResponseTumor Microenvironment

Substanzen

HydrogelsCeramidesImmunosuppressive Agents

Autor:innen und Institutionen

  • Laboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad, 121001, Haryana, India.
  • Laboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3 Milestone, Faridabad-Gurgaon Expressway, Faridabad, 121001, Haryana, India.
  • Amity Institute of Integrative Sciences and Health, Amity University Haryana, Panchgaon, Manesar, Gurgaon, 122413, Haryana, India.
  • National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Department of Chemistry, Indian Institute of Science Education and Research, Bhopal, 462066, Madhya Pradesh, India.
  • National Institute of Pathology, Safdarjung Hospital Campus, Ansari Nagar West, New Delhi, 110029, India.

ORCID-Profile: Animesh Kar, Dolly Jain, Sandeep Kumar, Kajal Rajput, Sanjay Pal, Kajal Rana, Raunak Kar, Somesh K Jha, Nihal Medatwal, Prabhu Srinivas Yavvari, Nishant Pandey, Devashish Mehta, Harsh Sharma, Debanjan Bhattacharya, Manas K Pradhan, Ravi Datta Sharma, Aasheesh Srivastava, Usha Agrawal, Arnab Mukhopadhyay, Sagar Sengupta, Avinash Bajaj, Ujjaini Dasgupta

Zitieren

APA

Kar, A., Jain, D., Kumar, S., Rajput, K., Pal, S., Rana, K., Kar, R., Jha, S. K., Medatwal, N., Yavvari, P. S., Pandey, N., Mehta, D., Sharma, H., Bhattacharya, D., Pradhan, M. K., Sharma, R. D., Srivastava, A., Agrawal, U., Mukhopadhyay, A., …, & Dasgupta, U. (2023). A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response. Science Advances. https://doi.org/10.1126/sciadv.adf2746

Vancouver

Kar A, Jain D, Kumar S, Rajput K, Pal S, Rana K, et al. A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response. Science Advances. 2023. doi:10.1126/sciadv.adf2746

BibTeX
@article{Kar2023,
  author = {Kar, Animesh and Jain, Dolly and Kumar, Sandeep and Rajput, Kajal and Pal, Sanjay and Rana, Kajal and Kar, Raunak and Jha, Somesh K and Medatwal, Nihal and Yavvari, Prabhu Srinivas and Pandey, Nishant and Mehta, Devashish and Sharma, Harsh and Bhattacharya, Debanjan and Pradhan, Manas K and Sharma, Ravi Datta and Srivastava, Aasheesh and Agrawal, Usha and Mukhopadhyay, Arnab and Sengupta, Sagar and Patil, Veena S and Bajaj, Avinash and Dasgupta, Ujjaini},
  title = {A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response},
  journal = {Science Advances},
  year = {2023},
  doi = {10.1126/sciadv.adf2746}
}
Kostenlos starten →